Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002866:Chromonar / Q000494:pharmacology*; D003374:Coumarins / Q000494:pharmacology*; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D013928:Thromboxane A2 / Q000097:blood*; D013931:Thromboxanes / Q000097:blood*
D001095:Arachidonic Acids; D003374:Coumarins; D013931:Thromboxanes; D016718:Arachidonic Acid; D013928:Thromboxane A2; D002866:Chromonar